Table 1 Demographic and baseline characteristics of the enrolled patients
Clinicopathological | No. of patients |
|---|---|
Characteristics | n, (%) |
Gender | |
Male | 43 (66.2) |
Female | 22 (33.8) |
ECOG performance status score | |
0 | 21 (32.3) |
1 | 38 (58.5) |
2 | 6 (9.2) |
Primary tumor location | |
Head | 32 (49.2) |
Body | 13 (20.0) |
Tail | 6 (9.2) |
Multicentric | 14 (21.6) |
No. of metastatic sites involved | |
Median | 1 |
Range | 1–4 |
Metastatic tumor sites | |
Liver | 53 (81.5) |
Lung | 14 (21.5) |
Lymph nodes | 19 (29.2) |
Peritoneum | 15 (23.1) |
Others | 7 (10.8) |
Cycles of mFOLFIRINOX | |
Median | 8 |
Range | 1–12 |